nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—AXL—refractive error	0.836	1	CbGaD
Vandetanib—Bosutinib—AXL—refractive error	0.00402	1	CrCbGaD
Vandetanib—EPHA8—eye—refractive error	0.0014	0.0962	CbGeAlD
Vandetanib—EPHA5—eye—refractive error	0.00109	0.0744	CbGeAlD
Vandetanib—EPHA5—retina—refractive error	0.00108	0.0737	CbGeAlD
Vandetanib—FLT4—eye—refractive error	0.000838	0.0575	CbGeAlD
Vandetanib—RIPK2—eye—refractive error	0.000834	0.0572	CbGeAlD
Vandetanib—RIPK2—retina—refractive error	0.000826	0.0566	CbGeAlD
Vandetanib—MKNK1—eye—refractive error	0.000749	0.0514	CbGeAlD
Vandetanib—MKNK1—retina—refractive error	0.000743	0.0509	CbGeAlD
Vandetanib—AXL—eye—refractive error	0.000737	0.0505	CbGeAlD
Vandetanib—AXL—retina—refractive error	0.000731	0.0501	CbGeAlD
Vandetanib—FMO3—eye—refractive error	0.000715	0.049	CbGeAlD
Vandetanib—YES1—eye—refractive error	0.000623	0.0427	CbGeAlD
Vandetanib—YES1—retina—refractive error	0.000617	0.0423	CbGeAlD
Vandetanib—SRC—eye—refractive error	0.000599	0.0411	CbGeAlD
Vandetanib—SRC—retina—refractive error	0.000594	0.0407	CbGeAlD
Vandetanib—KDR—eye—refractive error	0.000551	0.0378	CbGeAlD
Vandetanib—KDR—retina—refractive error	0.000546	0.0374	CbGeAlD
Vandetanib—PDGFRB—eye—refractive error	0.000477	0.0327	CbGeAlD
Vandetanib—ABL1—eye—refractive error	0.000425	0.0291	CbGeAlD
Vandetanib—ABL1—retina—refractive error	0.000421	0.0289	CbGeAlD
Vandetanib—LYN—B Cell Activation—PTEN—refractive error	2.78e-05	0.000192	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—COL9A1—refractive error	2.78e-05	0.000192	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—WNT10A—refractive error	2.77e-05	0.000191	CbGpPWpGaD
Vandetanib—EGFR—Downstream signal transduction—PTEN—refractive error	2.76e-05	0.00019	CbGpPWpGaD
Vandetanib—EGFR—Signaling by FGFR—PTEN—refractive error	2.75e-05	0.00019	CbGpPWpGaD
Vandetanib—EGFR—EGF/EGFR Signaling Pathway—PTEN—refractive error	2.75e-05	0.00019	CbGpPWpGaD
Vandetanib—FYN—B Cell Activation—PTEN—refractive error	2.74e-05	0.000189	CbGpPWpGaD
Vandetanib—SRC—Disease—RNF111—refractive error	2.74e-05	0.000189	CbGpPWpGaD
Vandetanib—EGFR—Signaling by ERBB2—PTEN—refractive error	2.73e-05	0.000189	CbGpPWpGaD
Vandetanib—PDGFRB—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	2.72e-05	0.000188	CbGpPWpGaD
Vandetanib—EGFR—DAP12 signaling—PTEN—refractive error	2.72e-05	0.000188	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—AXL—refractive error	2.71e-05	0.000187	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—RPS27—refractive error	2.71e-05	0.000187	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—RNF111—refractive error	2.7e-05	0.000186	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TJP2—refractive error	2.7e-05	0.000186	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CER1—refractive error	2.7e-05	0.000186	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—VIPR2—refractive error	2.69e-05	0.000186	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—COL9A1—refractive error	2.69e-05	0.000185	CbGpPWpGaD
Vandetanib—LCK—Disease—LUM—refractive error	2.68e-05	0.000185	CbGpPWpGaD
Vandetanib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	2.68e-05	0.000185	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—PDGFRA—refractive error	2.67e-05	0.000184	CbGpPWpGaD
Vandetanib—LCK—Downstream signal transduction—PTEN—refractive error	2.66e-05	0.000184	CbGpPWpGaD
Vandetanib—LCK—Signaling by FGFR—PTEN—refractive error	2.65e-05	0.000183	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—RNF111—refractive error	2.65e-05	0.000183	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CER1—refractive error	2.65e-05	0.000183	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TJP2—refractive error	2.65e-05	0.000183	CbGpPWpGaD
Vandetanib—LCK—Signaling by ERBB2—PTEN—refractive error	2.63e-05	0.000182	CbGpPWpGaD
Vandetanib—FYN—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	2.62e-05	0.000181	CbGpPWpGaD
Vandetanib—LCK—DAP12 signaling—PTEN—refractive error	2.62e-05	0.000181	CbGpPWpGaD
Vandetanib—SRC—Signaling by SCF-KIT—PTEN—refractive error	2.62e-05	0.000181	CbGpPWpGaD
Vandetanib—FYN—Disease—RPS27—refractive error	2.61e-05	0.00018	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—RNF111—refractive error	2.6e-05	0.00018	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CER1—refractive error	2.6e-05	0.00018	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TJP2—refractive error	2.6e-05	0.00018	CbGpPWpGaD
Vandetanib—LCK—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	2.58e-05	0.000178	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—VANGL2—refractive error	2.57e-05	0.000178	CbGpPWpGaD
Vandetanib—EGFR—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	2.56e-05	0.000177	CbGpPWpGaD
Vandetanib—EGFR—Signaling by FGFR in disease—PTEN—refractive error	2.56e-05	0.000177	CbGpPWpGaD
Vandetanib—EGFR—DAP12 interactions—PTEN—refractive error	2.56e-05	0.000177	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—PDGFRA—refractive error	2.54e-05	0.000175	CbGpPWpGaD
Vandetanib—EGFR—Signaling by EGFR—PTEN—refractive error	2.54e-05	0.000175	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RDH5—refractive error	2.53e-05	0.000175	CbGpPWpGaD
Vandetanib—SRC—Immune System—CTSC—refractive error	2.52e-05	0.000174	CbGpPWpGaD
Vandetanib—EGFR—Signaling by EGFR in Cancer—PTEN—refractive error	2.51e-05	0.000173	CbGpPWpGaD
Vandetanib—EGFR—Signaling by PDGF—PTEN—refractive error	2.5e-05	0.000173	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—VANGL2—refractive error	2.48e-05	0.000171	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—LUM—refractive error	2.48e-05	0.000171	CbGpPWpGaD
Vandetanib—LCK—DAP12 interactions—PTEN—refractive error	2.47e-05	0.00017	CbGpPWpGaD
Vandetanib—LCK—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	2.47e-05	0.00017	CbGpPWpGaD
Vandetanib—LCK—Signaling by FGFR in disease—PTEN—refractive error	2.47e-05	0.00017	CbGpPWpGaD
Vandetanib—LCK—Signaling by EGFR—PTEN—refractive error	2.44e-05	0.000169	CbGpPWpGaD
Vandetanib—LCK—Signaling by EGFR in Cancer—PTEN—refractive error	2.42e-05	0.000167	CbGpPWpGaD
Vandetanib—EGFR—Focal Adhesion—PTEN—refractive error	2.42e-05	0.000167	CbGpPWpGaD
Vandetanib—LCK—Signaling by PDGF—PTEN—refractive error	2.41e-05	0.000166	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	2.41e-05	0.000166	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—AXL—refractive error	2.4e-05	0.000166	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—WNT10A—refractive error	2.39e-05	0.000165	CbGpPWpGaD
Vandetanib—ABCC1—Disease—RPS27—refractive error	2.39e-05	0.000165	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—CACNA1D—refractive error	2.38e-05	0.000164	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—BMP2—refractive error	2.38e-05	0.000164	CbGpPWpGaD
Vandetanib—SRC—Disease—LUM—refractive error	2.38e-05	0.000164	CbGpPWpGaD
Vandetanib—EGFR—B Cell Activation—PTEN—refractive error	2.37e-05	0.000163	CbGpPWpGaD
Vandetanib—SRC—Downstream signal transduction—PTEN—refractive error	2.36e-05	0.000162	CbGpPWpGaD
Vandetanib—SRC—EGF/EGFR Signaling Pathway—PTEN—refractive error	2.34e-05	0.000162	CbGpPWpGaD
Vandetanib—SRC—Signaling by FGFR—PTEN—refractive error	2.34e-05	0.000162	CbGpPWpGaD
Vandetanib—SRC—Signaling by ERBB2—PTEN—refractive error	2.33e-05	0.000161	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—PDGFRA—refractive error	2.33e-05	0.00016	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—WNT10A—refractive error	2.31e-05	0.000159	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—PDGFRA—refractive error	2.3e-05	0.000159	CbGpPWpGaD
Vandetanib—LCK—B Cell Activation—PTEN—refractive error	2.28e-05	0.000157	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—PDGFRA—refractive error	2.28e-05	0.000157	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PML—refractive error	2.28e-05	0.000157	CbGpPWpGaD
Vandetanib—ALB—Transmembrane transport of small molecules—TUBB3—refractive error	2.27e-05	0.000156	CbGpPWpGaD
Vandetanib—EGFR—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	2.27e-05	0.000156	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—PDGFRA—refractive error	2.27e-05	0.000156	CbGpPWpGaD
Vandetanib—EGFR—Disease—RPS27—refractive error	2.25e-05	0.000155	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RNF111—refractive error	2.25e-05	0.000155	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TJP2—refractive error	2.25e-05	0.000155	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CER1—refractive error	2.25e-05	0.000155	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—PDGFRA—refractive error	2.24e-05	0.000155	CbGpPWpGaD
Vandetanib—IRAK4—Innate Immune System—PTEN—refractive error	2.24e-05	0.000155	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—PDGFRA—refractive error	2.23e-05	0.000154	CbGpPWpGaD
Vandetanib—LYN—Immune System—PML—refractive error	2.23e-05	0.000154	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PML—refractive error	2.22e-05	0.000153	CbGpPWpGaD
Vandetanib—BLK—Immune System—PDGFRA—refractive error	2.21e-05	0.000153	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—PDGFRA—refractive error	2.21e-05	0.000153	CbGpPWpGaD
Vandetanib—FGR—Immune System—PDGFRA—refractive error	2.2e-05	0.000152	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—VANGL2—refractive error	2.2e-05	0.000152	CbGpPWpGaD
Vandetanib—FYN—Immune System—PML—refractive error	2.19e-05	0.000151	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—PDGFRA—refractive error	2.19e-05	0.000151	CbGpPWpGaD
Vandetanib—LCK—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	2.18e-05	0.000151	CbGpPWpGaD
Vandetanib—SRC—Signaling by FGFR in disease—PTEN—refractive error	2.18e-05	0.000151	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—LUM—refractive error	2.18e-05	0.00015	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—BMP2—refractive error	2.18e-05	0.00015	CbGpPWpGaD
Vandetanib—ALB—Metabolism—DSE—refractive error	2.18e-05	0.00015	CbGpPWpGaD
Vandetanib—LCK—Disease—RPS27—refractive error	2.17e-05	0.00015	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TJP2—refractive error	2.17e-05	0.00015	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CER1—refractive error	2.17e-05	0.00015	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RNF111—refractive error	2.17e-05	0.00015	CbGpPWpGaD
Vandetanib—SRC—Signaling by EGFR—PTEN—refractive error	2.16e-05	0.000149	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—PDGFRA—refractive error	2.15e-05	0.000149	CbGpPWpGaD
Vandetanib—SRC—Signaling by EGFR in Cancer—PTEN—refractive error	2.14e-05	0.000148	CbGpPWpGaD
Vandetanib—SRC—Signaling by PDGF—PTEN—refractive error	2.14e-05	0.000147	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—BMP2—refractive error	2.12e-05	0.000146	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—CYP26A1—refractive error	2.1e-05	0.000145	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—BMP2—refractive error	2.1e-05	0.000145	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—CACNA1D—refractive error	2.1e-05	0.000145	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by NGF—PTEN—refractive error	2.09e-05	0.000144	CbGpPWpGaD
Vandetanib—SRC—Focal Adhesion—PTEN—refractive error	2.06e-05	0.000142	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	2.05e-05	0.000142	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—COL9A1—refractive error	2.05e-05	0.000141	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—WNT10A—refractive error	2.04e-05	0.000141	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—PDGFRA—refractive error	2.03e-05	0.00014	CbGpPWpGaD
Vandetanib—RIPK2—Innate Immune System—PTEN—refractive error	2.03e-05	0.00014	CbGpPWpGaD
Vandetanib—FYN—Signaling by NGF—PTEN—refractive error	2.02e-05	0.000139	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—COL9A1—refractive error	2e-05	0.000138	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—COL9A1—refractive error	1.97e-05	0.000136	CbGpPWpGaD
Vandetanib—RIPK2—Adaptive Immune System—PTEN—refractive error	1.95e-05	0.000134	CbGpPWpGaD
Vandetanib—FGR—Innate Immune System—PTEN—refractive error	1.94e-05	0.000134	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PLA2G16—refractive error	1.94e-05	0.000134	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PCCA—refractive error	1.94e-05	0.000134	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—PDGFRA—refractive error	1.94e-05	0.000134	CbGpPWpGaD
Vandetanib—SRC—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	1.93e-05	0.000133	CbGpPWpGaD
Vandetanib—SRC—Disease—RPS27—refractive error	1.92e-05	0.000133	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RNF111—refractive error	1.92e-05	0.000132	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CER1—refractive error	1.92e-05	0.000132	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TJP2—refractive error	1.92e-05	0.000132	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—BMP2—refractive error	1.91e-05	0.000132	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PML—refractive error	1.89e-05	0.000131	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—PTEN—refractive error	1.87e-05	0.000129	CbGpPWpGaD
Vandetanib—ERBB3—Disease—PDGFRA—refractive error	1.87e-05	0.000129	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—PDGFRA—refractive error	1.87e-05	0.000129	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—PDGFRA—refractive error	1.86e-05	0.000128	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—CYP26A1—refractive error	1.85e-05	0.000128	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—BMP2—refractive error	1.84e-05	0.000127	CbGpPWpGaD
Vandetanib—LCK—Immune System—PML—refractive error	1.83e-05	0.000126	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—PDGFRA—refractive error	1.79e-05	0.000124	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—PTEN—refractive error	1.79e-05	0.000123	CbGpPWpGaD
Vandetanib—YES1—Immune System—PDGFRA—refractive error	1.78e-05	0.000123	CbGpPWpGaD
Vandetanib—EGFR—Signaling by NGF—PTEN—refractive error	1.74e-05	0.00012	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—PTEN—refractive error	1.72e-05	0.000118	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—COL9A1—refractive error	1.71e-05	0.000118	CbGpPWpGaD
Vandetanib—LCK—Signaling by NGF—PTEN—refractive error	1.68e-05	0.000116	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—PDGFRA—refractive error	1.65e-05	0.000114	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—COL9A1—refractive error	1.64e-05	0.000113	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—PTEN—refractive error	1.64e-05	0.000113	CbGpPWpGaD
Vandetanib—MKNK1—Disease—PTEN—refractive error	1.62e-05	0.000112	CbGpPWpGaD
Vandetanib—SRC—Immune System—PML—refractive error	1.62e-05	0.000112	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—PDGFRA—refractive error	1.59e-05	0.000109	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—PTEN—refractive error	1.57e-05	0.000108	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—EBP—refractive error	1.55e-05	0.000107	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—PTEN—refractive error	1.51e-05	0.000104	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—PTEN—refractive error	1.5e-05	0.000103	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—PTEN—refractive error	1.49e-05	0.000103	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—PDGFRA—refractive error	1.49e-05	0.000103	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—COL9A1—refractive error	1.45e-05	0.0001	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—PTEN—refractive error	1.43e-05	9.88e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—BMP2—refractive error	1.4e-05	9.68e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—BMP2—refractive error	1.37e-05	9.48e-05	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—PTEN—refractive error	1.37e-05	9.45e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—PDGFRA—refractive error	1.36e-05	9.38e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PDGFRA—refractive error	1.35e-05	9.35e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—BMP2—refractive error	1.35e-05	9.33e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—LUM—refractive error	1.34e-05	9.27e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—PDGFRA—refractive error	1.33e-05	9.15e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—PDGFRA—refractive error	1.32e-05	9.14e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PDGFRA—refractive error	1.32e-05	9.11e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—PDGFRA—refractive error	1.31e-05	9.04e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—PDGFRA—refractive error	1.31e-05	9.01e-05	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—PTEN—refractive error	1.3e-05	9e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CACNA1D—refractive error	1.29e-05	8.93e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—PDGFRA—refractive error	1.25e-05	8.63e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—PDGFRA—refractive error	1.21e-05	8.32e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—PTEN—refractive error	1.19e-05	8.24e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—PDGFRA—refractive error	1.19e-05	8.21e-05	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—PTEN—refractive error	1.18e-05	8.14e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—DSE—refractive error	1.17e-05	8.1e-05	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—PTEN—refractive error	1.17e-05	8.07e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—BMP2—refractive error	1.17e-05	8.06e-05	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—PTEN—refractive error	1.16e-05	8.03e-05	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—PTEN—refractive error	1.15e-05	7.94e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—PDGFRA—refractive error	1.15e-05	7.93e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—PTEN—refractive error	1.15e-05	7.91e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CYP26A1—refractive error	1.14e-05	7.88e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—PTEN—refractive error	1.14e-05	7.83e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—PTEN—refractive error	1.14e-05	7.83e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—PTEN—refractive error	1.13e-05	7.81e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PDGFRA—refractive error	1.13e-05	7.78e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—BMP2—refractive error	1.13e-05	7.77e-05	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—PTEN—refractive error	1.12e-05	7.75e-05	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—PTEN—refractive error	1.11e-05	7.63e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PDGFRA—refractive error	1.11e-05	7.62e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—PDGFRA—refractive error	1.09e-05	7.5e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—PTEN—refractive error	1.07e-05	7.36e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PCCA—refractive error	1.05e-05	7.22e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PLA2G16—refractive error	1.05e-05	7.22e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—PDGFRA—refractive error	1.04e-05	7.19e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—PTEN—refractive error	1.04e-05	7.18e-05	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—PTEN—refractive error	1.02e-05	7.06e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—PDGFRA—refractive error	1e-05	6.92e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—BMP2—refractive error	9.97e-06	6.88e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—PTEN—refractive error	9.94e-06	6.86e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—PDGFRA—refractive error	9.62e-06	6.64e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—PTEN—refractive error	9.61e-06	6.63e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—PTEN—refractive error	9.58e-06	6.61e-05	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—PTEN—refractive error	9.55e-06	6.59e-05	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—PTEN—refractive error	9.2e-06	6.35e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—PTEN—refractive error	9.13e-06	6.3e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—PDGFRA—refractive error	8.89e-06	6.13e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PDGFRA—refractive error	8.76e-06	6.04e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PDGFRA—refractive error	8.58e-06	5.92e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—PTEN—refractive error	8.48e-06	5.85e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PDGFRA—refractive error	8.44e-06	5.82e-05	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—PTEN—refractive error	8.15e-06	5.62e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—PTEN—refractive error	7.63e-06	5.26e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PDGFRA—refractive error	7.29e-06	5.03e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—LUM—refractive error	7.26e-06	5.01e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PDGFRA—refractive error	7.03e-06	4.85e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CACNA1D—refractive error	6.98e-06	4.82e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—PTEN—refractive error	6.98e-06	4.81e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PTEN—refractive error	6.96e-06	4.8e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—PTEN—refractive error	6.81e-06	4.7e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—PTEN—refractive error	6.8e-06	4.69e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PTEN—refractive error	6.78e-06	4.68e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—PTEN—refractive error	6.73e-06	4.64e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—PTEN—refractive error	6.7e-06	4.63e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—PTEN—refractive error	6.42e-06	4.43e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PDGFRA—refractive error	6.22e-06	4.29e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—PTEN—refractive error	6.19e-06	4.27e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP26A1—refractive error	6.17e-06	4.26e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—PTEN—refractive error	6.11e-06	4.22e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—PTEN—refractive error	5.9e-06	4.07e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PTEN—refractive error	5.79e-06	4e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PTEN—refractive error	5.79e-06	4e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PTEN—refractive error	5.67e-06	3.91e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—PTEN—refractive error	5.58e-06	3.85e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTEN—refractive error	5.35e-06	3.69e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—PTEN—refractive error	5.15e-06	3.56e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—PTEN—refractive error	4.94e-06	3.41e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTEN—refractive error	4.75e-06	3.28e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—PTEN—refractive error	4.56e-06	3.15e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PTEN—refractive error	4.5e-06	3.1e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PTEN—refractive error	4.4e-06	3.04e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PTEN—refractive error	4.33e-06	2.99e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTEN—refractive error	4.18e-06	2.88e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PTEN—refractive error	3.74e-06	2.58e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PTEN—refractive error	3.61e-06	2.49e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PTEN—refractive error	3.19e-06	2.2e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTEN—refractive error	2.58e-06	1.78e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTEN—refractive error	1.39e-06	9.61e-06	CbGpPWpGaD
